GW Pharmaceuticals PLC (NASDAQ:GWPH)

129.02
Delayed Data
As of Jul 08
 -0.62 / -0.48%
Today’s Change
67.98
Today|||52-Week Range
180.75
+23.39%
Year-to-Date
3 Marijuana Stock Winners in the First Half of 2020 That Are Still Great Picks
6:49am / MotleyFool.com - Paid Partner Content
Where Will GW Pharmaceuticals Be in 1 Year?
Jun 29 / MotleyFool.com - Paid Partner Content
The 5 Best Pot Stocks in the First Half of 2020
Jul 07 / MotleyFool.com - Paid Partner Content
Better Buy: GW Pharmaceuticals vs. Cara Therapeutics
Jun 28 / MotleyFool.com - Paid Partner Content
Is GW Pharmaceuticals Stock a Buy?
Jun 30 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close129.62
Today’s open129.36
Day’s range127.71 - 129.59
Volume124,514
Average volume (3 months)439,873
Market cap$3.9B
Data as of 4:57pm ET, 07/08/2020

Growth & Valuation

Earnings growth (last year)+96.96%
Earnings growth (this year)-605.38%
Earnings growth (next 5 years)+42.59%
Revenue growth (last year)+1,918.66%
P/E ratio107.5
Price/Sales10.36
Price/Book5.35

Competitors

 Today’s
change
Today’s
% change
FOLDAmicus Therapeutics ...-0.11-0.69%
----
CCXIChemoCentryx Inc+2.89+4.91%
CBPOChina Biologic Produ...+0.86+0.80%
Data as of 3:59pm ET, 07/08/2020

Financials

Next reporting dateAugust 11, 2020
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$312.6M
Annual profit (last year)-$9.1M
Net profit margin-2.90%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
No executives to display
Corporate headquarters
Cambridge, Cambridgeshire

Forecasts